[HTML][HTML] A non-coronary, peripheral arterial atherosclerotic disease (carotid, renal, lower limb) in elderly patients—A review: Part I—Epidemiology, risk factors, and …

M Piechocki, T Przewłocki, P Pieniążek… - Journal of Clinical …, 2024 - mdpi.com
Atherosclerosis is a generalized and progressive disease. Ageing is a key risk factor for
atherosclerosis progression that is associated with the increased incidence of ischemic …

[HTML][HTML] Comparative roles of IL-1, IL-6, IL-10, IL-17, IL-18, 1L-22, IL-33, and IL-37 in various cardiovascular diseases with potential insights for targeted …

M Abubakar, HF Rasool, I Javed, S Raza, L Abang… - Cureus, 2023 - ncbi.nlm.nih.gov
In recent years, the study of interleukins (ILs), crucial cytokines involved in immune response
and inflammation, has garnered significant attention within the sphere of cardiovascular …

[HTML][HTML] Interleukins: pathogenesis in non-alcoholic fatty liver disease

S Rafaqat, S Gluscevic, F Mercantepe, S Rafaqat… - Metabolites, 2024 - mdpi.com
Inflammatory cytokines have been implicated as crucial contributors to the onset and
progression of non-alcoholic fatty liver disease (NAFLD). The exact mechanisms by which …

[HTML][HTML] Macrophage-associated markers of metaflammation are linked to metabolic dysfunction in pediatric obesity

J Lischka, A Schanzer, C de Gier, S Greber-Platzer… - Cytokine, 2023 - Elsevier
Backgpound Metabolically driven chronic low-grade adipose tissue inflammation, so-called
metaflammation, is a central feature in obesity. This inflammatory tone is largely driven by …

Cardio-rheumatology: the cardiovascular, pharmacological, and surgical risks associated with rheumatological diseases in women

SL Sommer, MI Kontaridis - Canadian Journal of Physiology …, 2024 - cdnsciencepub.com
Cardiovascular disease (CVD) remains the number one cause of death worldwide. Women
are at increased risk of death from CVD, but the mechanisms for how and why this occurs …

Differential changes in maternal proinflammatory IL6 plasma levels as a putatively surrogate marker of candidacy and clinical utility during mid-and late pregnancy …

A Albsoul, N Bulatova, V Kasabri… - Pharmacy Practice …, 2024 - dialnet.unirioja.es
Background/methods: The impact of clinical pharmacist on undiagnosed pregnancy
hyperglycemia (PHG) in mid-and late-pregnancy as a major preventable cause of maternal …

In vitro examinations of the anti-inflammatory interleukin functionalized polydopamine based biomaterial as a potential coating for cardiovascular stents

P Sareło, B Sobieszczańska, E Wysokińska… - Biocybernetics and …, 2023 - Elsevier
Despite advances in stent technologies, restenosis remains a serious problem of
interventional cardiology and is considered as a consequence of the progressing …

[HTML][HTML] Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease

F Yang, N Huangfu, J Shen, P Su, L Zhu… - Frontiers in …, 2023 - frontiersin.org
Aims Epidemiological evidence for the link of interleukin 1 (IL-1) and its inhibition with
cardiovascular diseases (CVDs) remains controversial. We aim to investigate the …

[HTML][HTML] Increased carotid intima-media thickness and cardiometabolic risk factors are associated with IL-6 gene polymorphisms in Mexican individuals: The Genetics …

R Posadas-Sánchez, ÁR López-Uribe… - Biomolecules and …, 2024 - ncbi.nlm.nih.gov
Abstract Interleukin 6 (IL-6) is a cytokine implicated in the development of atherosclerosis.
This study aimed to determine the association of three IL-6 gene polymorphisms with …

Recent Advances in Peripheral Artery Disease

F Biscetti - Hearts, 2023 - mdpi.com
Despite its significant impact on patients' lives and the healthcare system, peripheral arterial
disease (PAD) has long been overshadowed by other cardiovascular diseases [1]. Originally …